Form 4: Biolife Solutions CTO Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Sean Werner, Chief Technology Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.

Summary

  • Grant/award: acquired 45,838 Common Stock on October 6, 2026; holds 47,033 after (Direct).
  • Grant/award: acquired 48,232 Common Stock on October 6, 2026; holds 95,265 after (Direct).
  • Tax/exercise-price withholding: disposed of 71,226 Common Stock at $38.61 ($2,750,036) on October 6, 2026; holds 24,039 after (Direct).
  • Disposition to the issuer: disposed of 69,979 Common Stock on October 6, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Sean Werner — Officer (Chief Technology Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-06Grant/awardCommon Stock45,838——47,033
2026-10-06Grant/awardCommon Stock48,232——95,265
2026-10-06Tax/exercise-price withholdingCommon Stock71,226$39$2.8M24,039
2026-10-06Disposition to the issuerCommon Stock69,979——0

Key Dates

DateDescription
2026-10-06Grant/award (45,838 shares)
2026-10-06Grant/award (48,232 shares)
2026-10-06Tax/exercise-price withholding (71,226 shares)
2026-10-06Disposition to the issuer (69,979 shares)

Keywords

insider transaction, Form 4, BLFS, BIOLIFE SOLUTIONS INC, neutral, Sean Werner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.